“Evaluating The Safety Profile Of Nintedanib Among ILD Patients In A Tertiary Care Hospital: A Prospective Research Approach Focusing On Adverse Drug Reactions” (2025) International Journal of Environmental Sciences, pp. 5496–5502. doi:10.64252/69nwp181.